Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-5-19
pubmed:abstractText
Evidence on the role of high-sensitivity C-reactive protein (hsCRP) at different stages of atherosclerosis is limited. We therefore analyzed the relationship between hsCRP and measures of subclinical and advanced atherosclerosis in a population-based sample of the INVADE study (n = 3,092, >55 years). The parameters of interest were IMT, ABI, and the stage of atherosclerosis. Differences between participants with normal and pathological hsCRP were analyzed by t test for independent samples or Fishers' exact test. Differences of hsCRP between IMT quartiles, ABI quartiles, and different stages of atherosclerosis were analyzed by one-way ANOVA. Adjusted stepwise multiple linear regression analysis (IMT and ABI) and adjusted analysis of variance (stage of atherosclerosis) were performed, including significant baseline parameters as covariates. ANOVA showed significant differences of hsCRP among IMT quartiles, ABI quartiles, and patients with and without atherosclerosis. The adjusted analyses confirmed that the effects of IMT, ABI, and atherosclerosis on hsCRP were independent from other significant baseline parameters, but did not yield a significant difference between subclinical and advanced stages of atherosclerosis. The present analysis indicates an independent relationship between hsCRP and both IMT and ABI as measures of subclinical atherosclerosis. The comparison of subclinical and advanced stages of atherosclerosis yielded no significant difference, indicating that hsCRP is sensitive to identify vascular risk patients, but not suited to monitor progression of the disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1432-1459
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
256
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
783-91
pubmed:meshHeading
pubmed-meshheading:19240956-Aged, pubmed-meshheading:19240956-Atherosclerosis, pubmed-meshheading:19240956-Biological Markers, pubmed-meshheading:19240956-Blood Pressure, pubmed-meshheading:19240956-C-Reactive Protein, pubmed-meshheading:19240956-Carotid Stenosis, pubmed-meshheading:19240956-Cohort Studies, pubmed-meshheading:19240956-Disease Progression, pubmed-meshheading:19240956-Female, pubmed-meshheading:19240956-Germany, pubmed-meshheading:19240956-Humans, pubmed-meshheading:19240956-Inflammation, pubmed-meshheading:19240956-Male, pubmed-meshheading:19240956-Middle Aged, pubmed-meshheading:19240956-Predictive Value of Tests, pubmed-meshheading:19240956-Prognosis, pubmed-meshheading:19240956-Sensitivity and Specificity, pubmed-meshheading:19240956-Severity of Illness Index, pubmed-meshheading:19240956-Tibial Arteries, pubmed-meshheading:19240956-Ultrasonography, pubmed-meshheading:19240956-Up-Regulation
pubmed:year
2009
pubmed:articleTitle
High-sensitivity C-reactive protein at different stages of atherosclerosis: results of the INVADE study.
pubmed:affiliation
Department of Psychiatry, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, Muenchen 81675, Germany. csh76@gmx.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't